Healthy Controls
97
25
27
41
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.2%
6 terminated out of 97 trials
87.2%
+0.6% vs benchmark
8%
8 trials in Phase 3/4
22%
9 of 41 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 41 completed trials
Clinical Trials (97)
Pilot Study of Personalized Aperiodic Transcranial Alternating Current Stimulation in Antenatal Depression (PandA-tACS)
HA35 Acute Alcohol Study
Characterization of Muscle Activity During a Surface EMG-controlled Rehabilitation Game
NeuroCatch Reference Interval Database
A Repository to Study Host-Microbiome Interactions in Health and Disease
Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers
Mass Spectrometry-based Immune Profiling in Autoimmune Diseases
Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study
Accessory Inspiratory Muscles in Chronic Neck Pain
Specimen and Data Collection in South Carolina Medicaid-Enrolled Patients With Type 2 Diabetes (T2D) and Metabolically Healthy Controls
Effect of Magnesium Supplementation on Sleep Quality and Cognitive Function in Saudi Adults
Reliability of [18F]-FTC-146 Brain Uptake in Healthy Controls
Impact of Epilepsy on the Brainstem Adenosine Pathway and Its Relation With Arousal and Respiratory Reactivity
Identification of a Safe and Non-Psychedelic Dose of Psilocybin
Effects of Exogenous Ketones on Cognitive Function in Older Adults With Prediabetes?
Exploring the Genetics of Schizophrenia in Manitoba
Intranasal Insulin and Olanzapine Study in Healthy Volunteers
A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome
Temporal Interference Stimulation for Social Cognition
Decoding Emotional Dynamics in Bipolar Disorder